scispace - formally typeset
I

Ignasi Gich

Researcher at Cochrane Collaboration

Publications -  15
Citations -  762

Ignasi Gich is an academic researcher from Cochrane Collaboration. The author has contributed to research in topics: Randomized controlled trial & Health care. The author has an hindex of 10, co-authored 15 publications receiving 653 citations. Previous affiliations of Ignasi Gich include Autonomous University of Barcelona.

Papers
More filters
Journal ArticleDOI

The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies.

TL;DR: Despite some increase in quality of CPGs over time, the quality scores as measured with the AGREE Instrument have remained moderate to low over the last two decades and urges guideline developers to continue improving the quality of their products.
Journal ArticleDOI

Quality Assessment of Asthma Clinical Practice Guidelines : A Systematic Appraisal

TL;DR: The quality of guidelines for asthma care is low, although it has improved over time and greater efforts are needed to provide high-quality guidelines that can be used as reliable tools for clinical decision-making in this field.
Journal ArticleDOI

Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.

TL;DR: To better characterize the distribution of patient and physician values and preferences relevant to decisions regarding anticoagulation in patients with AF, interviews with patients at risk of developing AF and physicians who manage patients withAF were conducted.
Journal ArticleDOI

A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease.

TL;DR: Treatment with calcium dobesilate was not found to be superior to placebo on the QoL of CVD patients and the sustained effect of calcium do Besilate observed after treatment should be confirmed in future studies.
Journal Article

Effectiveness of tranexamic acid in revision total knee arthroplasty.

TL;DR: TXA administration appeared as an effective and safe means of reducing blood transfusion requirements and blood loss in revision total knee arthroplasty.